Zoetis shares rose 5.4% on Tuesday after Q4 2022 results showed the company's growth back on track; the P/E is now back to 35x. Operational revenue growth was 9% in Q4, with strong growth in key new ...
Nomura Value Fund discusses its new position in Zoetis Inc. after selling Kenvue during Q4 2025. Read the full analysis for ...
Zoetis (NYSE:ZTS) has entered into a definitive agreement to acquire Neogen Corporation's animal genomics business. The ...
PARSIPPANY, N.J. & RUTHERFORD, New South Wales, Australia--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS) today announced it has completed the acquisition of Jurox, a privately held animal health company ...
FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced an agreement to purchase PHARMAQ, the global leader in vaccines and innovation for health products in aquaculture, for a ...
Zoetis Inc. ZTS is a Florham Park, NJ-based animal health company, which is a leader in the animal health space with a focus on both livestock and companion animals. The company operates in seven ...
StockStory.org on MSN
Zoetis (NYSE:ZTS) Posts Q4 Sales In Line With Estimates But Stock Drops
Animal health company Zoetis (NYSE:ZTS) in Q4 CY2024, with sales up 4.7% year on year to $2.32 billion. On the other hand, the company’s full-year revenue guidance of $9.3 billion at the midpoint came ...
PARSIPPANY, N.J. & RUTHERFORD, Australia--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS) today announced it has entered into an agreement to acquire Jurox, a privately held animal health company, which ...
Zoetis has proven to investors that the pharmaceutical apple doesn't fall far from the tree. What makes Zoetis's business attractive is the depth and breadth of its offerings, which include vaccines, ...
(Reuters) -Zoetis Inc on Thursday reported weaker-than-expected sales in its largest business unit as distributors de-stocked on pet products. The veterinary drugmaker reported pet products revenue of ...
FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that it has completed the purchase of PHARMAQ, the global leader in vaccines and innovation for health products in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results